Replies to post #107168 on Biotech Values

[jbog]

10b5-1 selling plan in effect.

10b5-1 is the biggest piece of garbage ever written. It let's someone set a selling plan ahead of time (when they possess no material info) and them gives the power to cancel any transaction at any time.

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 11/17/10.]


The table entries below include both ordinary and restricted
shares and both vested and non-vested options.

 
                             Shares    Options 
 Officers 
 *Craig Wheeler (CEO)       342,501    675,000 
 *G Venkataraman (SVP/R&D)  326,705    189,325 
 *John Bishop (SVP/Pharma)   48,103    121,860 
 *Richard Shea (CFO)         39,476    249,200 
 *Bruce Leicher (Gen Cnsl)   38,780    137,050 
 *James Roach (CMO)          17,840    205,250 
  
 Directors 
 John Clarke                 77,123    126,000 
 Bruce Downey                     0     45,000 
 Marsha Fanucci                   0    126,000 
 Peter Hutt                  67,863    201,500 
 *Bennett Shapiro             7,000    140,450 
 Elizabeth Stoner                 0     79,200 
 James Sulat                      0     60,000 
 ======================== =========  ========= 
 All thirteen insiders      965,391  2,355,835

*10b5-1 selling plan in effect.